Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 9%
Hold 64%
Sell 0%
Strong Sell 0%

Bulls say

Universal Health Services is supported by a favorable mix of scale, margin, and growth catalysts, with behavioral health generating just over half of consolidated operating income and over 55% of pretax profits despite acute care representing more than 55% of revenue. The company’s 1Q26 consolidated adjusted EBITDA rose 8.4% year over year, helped by pricing strength and higher acuity mix, while behavioral health posted same-store revenue growth of 7.3% and adjusted EBITDA growth of 8% amid moderating labor pressure. Its positive outlook also reflects continued capacity expansion, potential upside from state directed payment programs and Florida approvals, and a disciplined capital plan including $800-900m in share repurchases and the Talkspace acquisition.

Bears say

Universal Health Services is facing a negative fundamental setup because its business mix leaves it exposed to sluggish acute care volumes and margin pressure, while more profitable behavioral health operations are vulnerable to tight state budgets and regulatory shifts. Concentration risk in Nevada, Texas, and California heightens earnings volatility, and the 2020 cyberattack showed how operational disruptions can carry meaningful financial cost, with an estimated $67MM pre-tax impact. On top of that, a possible Medicare-For-All or ACA repeal-and-replace framework, tighter clinical labor supply, and reimbursement pressure could keep FY27 earnings about 5% below estimates and compress valuation multiples.

UHS has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 9% recommend Buy, 64% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Buy based on their latest research and market trends.

According to 11 analysts, UHS has a Buy consensus rating as of Oct 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $196.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $196.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.